Medartis Holding AG operates globally as a specialized provider of advanced orthopedic and osteosynthesis solutions for the treatment of bone fractures and deformities. The company's business is structured around two primary clinical areas: Cranio-Maxillofacial (CMF) surgery and Extremities, which focuses on the hand, wrist, elbow, foot, and ankle. Its flagship product families, including APTUS and MODUS, utilize proprietary technologies such as the TriLock variable angle locking system to provide surgeons with enhanced stability and flexibility during bone fixation. Medartis conducts its manufacturing in-house in Switzerland to maintain strict quality control over its precision engineering processes. The company distributes its medical devices through a direct sales force and a network of distributors across the EMEA, Americas, and Asia-Pacific regions, maintaining a strong competitive position in specialized orthopedic markets.